The conditions, in particular the requirements for relabelling and repackaging, should therefore be specified in this Regulation, taking into account the case-law of the Court of Justice [11] in other relevant sectors and existing good practice in the field of in vitro diagnostic medical devices.
Ba cheart, dá bhrí sin, na coinníollacha, go háirithe na ceanglais maidir le hathlipéadú agus athphacáistiú, a shonrú sa Rialachán seo, gan neamhaird a dhéanamh de chásdlí na Cúirte Breithiúnais [11] in earnálacha ábhartha eile ná den dea-chleachtas atá ann faoi láthair i réimse na bhfeistí leighis diagnóiseacha in vitro.